About Anaptysbio (ANAB)
AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more
- USD37.71
- USD38.85
- USD36.89
- USD38.82
- 56.10%
- 23M
- 288.20k
- 301.81k
- 921M
- 13.36
- 111.40%
Stock News
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
yesterday
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Yahoo
yesterday
Search competition fears hit Alphabet stock yet again. We see no reason to join the sellers
CNBC
yesterday
ATI Physical Therapy to Announce Second Quarter 2024 Financial Results
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
